Exclusive Interview with Dr. Robert Wong from Stanford University School of Medicine

On May 19, 2024, the M&TOD Editorial Office had the privilege of interviewing Dr. Robert Wong, a leading expert in viral hepatitis research. Dr. Wong, Clinical Associate Professor of Medicine (Affiliated) at Stanford University, has recently joined the M&TOD Editorial Board.

During the interview, Dr. Wong discussed his significant achievements in viral hepatitis research, including advancements in antiviral therapies. He also elaborated on the recent ACG Clinical Guideline on Focal Liver Lesions, highlighting its role in standardizing diagnostic and management practices.

As a new member of the M&TOD Editorial Board, Dr. Wong has proposed strategies to enhance the journal’s visibility and academic impact. His expertise and vision are expected to bring fresh perspectives and valuable guidance to the journal.

The M&TOD Editorial Office appreciates Dr. Wong’s time and looks forward to his contributions to advancing the field of hepatology.

Interview Questions:

1. With your expertise in viral hepatitis research, could you share some of your greatest achievements in this field?

2. You recently published an article on ACG Clinical Guideline: Focal Liver Lesions. Could you discuss the main recommendations of this guideline and its impact on clinical practice?

3. You've achieved remarkable success in the field of hepatology. Are there any particularly memorable or motivating stories from your career that you would like to share?

4. What advice would you offer to aspiring young medical students looking to make an impact in the field?

5. As a new Editorial Board member of M&TOD, what key suggestions do you have for enhancing the journal's visibility and academic influence？

Personal Introduction:

Robert J. Wong, MD, MS, FACG, FAASLD, is a Clinical Associate Professor of Medicine in the Division of Gastroenterology and Hepatology at Stanford University School of Medicine, and a staff physician at the Veterans Affairs Palo Alto Healthcare System. His clinical interests include the management of patients with complex liver diseases, including viral hepatitis, hepatocellular carcinoma, and steatotic liver disease. His research focuses on the epidemiology, outcomes, and health services related to chronic liver diseases, with a particular focus on healthcare disparities among underserved, vulnerable, and ethnic minority populations. His research has been funded by the National Institutes of Health (R01), the American Association for the Study of Liver Diseases (2017-2019 CTORA Career Development Award), the American College of Gastroenterology, and others. His work has been published in high-impact journals such as JAMA, Hepatology, Gastroenterology, Journal of Hepatology, Clinical Gastroenterology and Hepatology, and The American Journal of Gastroenterology. Dr. Wong serves on the Editorial Boards of Hepatology and Journal of Clinical Gastroenterology and is the current Editor-in-Chief of Gastroenterology Research. He has authored over 250 publications with an H-index of 54.

Editor: Jennifer Lee
Language Editor: Catherine Yang
Production Editor: Yan Zhang
Respectfully Submitted by the Editorial Office of Metabolism and Target Organ Damage